Bio-Connect

Topoisomerase II alpha antibody [C3], C-term

GTX100689
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetTOP2A
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Topoisomerase II alpha antibody [C3], C-term
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID7153
  • Target name
    TOP2A
  • Target description
    DNA topoisomerase II alpha
  • Target synonyms
    DNA gyrase; DNA topoisomerase (ATP-hydrolyzing); DNA topoisomerase 2-alpha; DNA topoisomerase II, 170 kD; DNA topoisomerase II, alpha isozyme; TOP2; TOP2alpha; TOPIIA; topoisomerase (DNA) II alpha 170kDa; TP2A
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP11388
  • Protein Name
    DNA topoisomerase 2-alpha
  • Scientific Description
    This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromsome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. [provided by RefSeq]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.
    Read more
  • In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells. Chen JC et al., 2019 Sep 9, Biomolecules
    Read more
  • Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining. Liu TP et al., 2018 Nov, R Soc Open Sci
    Read more
  • Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells. Jeon KH et al., 2018 May, Biochim Biophys Acta Gen Subj
    Read more
  • PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma. Lin ST et al., 2015 Jun, Cell Mol Life Sci
    Read more
  • Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. Lin ST et al., 2012 Oct 22, J Proteomics
    Read more